by In2Pharma | Jun 4, 2026 | News
Belgium The Belgian Health Authorities (FAMHP) have recently published a guidance document on the interpretation of Article 10 of the Law of 25 March 1964 regarding premiums and benefits. This document aims to further clarify the legal framework governing the granting...
by In2Pharma | Jun 3, 2026 | News
Europe As previously announced, as of 28 May 2026, the use of key modules of EUDAMED, the European database on medical devices, has become mandatory. The following modules are now in scope: Actors (economic operator registration)UDI/Devices (device...
by In2Pharma | Jun 2, 2026 | News
Luxembourg There is a new law in Luxembourg on materials and articles intended to come into contact with food, in line with Regulation (EU) 2017/625. This law also sets out the activities and controls carried out by the Luxembourg Veterinary and Food Administration...
by In2Pharma | Jun 2, 2026 | News
Belgium An update has been shared about the implementation timeline and scope of the Stock Monitoring Tool (SMT). Based on the latest information, the implementation of the SMT will be postponed to a later date, which is yet to be determined. In addition, several...
by In2Pharma | May 5, 2026 | News
The Netherlands A change has been made to the notification form of the Medicine Shortages and Defects Notification Centre in response to a new policy rule. The new policy rule and notification form have been implemented as of 01 April 2026. In the Netherlands,...
by In2Pharma | Apr 7, 2026 | News
The Netherlands The CGR communicated on three planned topics where updates to Dutch legislation are being proposed: Transparency register: Currently, transparency is based on self-regulation. A proposal to introduce a legal base for transparency in the...
